Abstract
Background
The American Joint Committee on Cancer’s 8th edition introduced ypStage, a separate staging system for patients with gastric cancer having undergone preoperative therapy. Overall, ypN0 patients have better survival outcomes than ypN+ patients. However, whether patients with cN+/ypN0 disease (“downstaged N0”) and those with cN0/ypN0 disease (“natural N0”) have similar survival is unknown.
Methods
An institutional database was reviewed to identify gastric adenocarcinoma patients who underwent potentially curative R0 resection after induction chemotherapy or chemoradiation. Patients were categorized into three groups based on nodal status: cN0/ypN0, cN+/ypN0, and ypN+. Univariable and multivariable Cox regression models were used to identify clinicopathologic factors associated with overall survival (OS).
Results
We identified 316 patients who met the study criteria. Ninety-four patients (30%) had cN0/ypN0 disease, 93 (29%) had cN+/ypN0 disease, and 129 (41%) had ypN+ disease. The median OS was 7.7 years, and the 5-year OS was 60.3%. In the multivariate analysis, OS did not differ between the cN0/ypN0 and cN+/ypN0 patients (hazard ratio, 0.90 [95% CI 0.54–1.48]; p = 0.666), but it was shorter in ypN+ patients (hazard ratio, 1.82 [95% CI 1.15–2.87]; p = 0.01).
Conclusions
In gastric cancer patients who underwent preoperative therapy, we found similar OS in cN0/ypN0 and cN+/ypN0 patients. Because ypN+ patients had poor OS, achieving ypN0 status is an important hallmark demonstrating the effectiveness of preoperative therapy for gastric cancer.
Similar content being viewed by others
References
Badgwell B. Multimodality therapy of localized gastric adenocarcinoma. J Natl Compr Cancer Netw. 2016;14(10):1321–27.
Badgwell B, Das P, Ajani J. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol. 2017;10(1):149.
Ikoma N, Cormier JN, Feig B, et al. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006–2014. Cancer. 2018;124(5):998–1007.
Leong T, Smithers BM, Michael M, et al. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG). BMC Cancer. 2015;15:532.
Amin MB, Edge S, Greene F, et al. AJCC Cancer Staging Manual 8th edition. New York: Springer; 2017.
Ikoma N, Blum M, Estrella JS, et al. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy. Gastric Cancer. 2018;21(1):74–83.
Ikoma N, Das P, Blum M, et al. Preoperative chemoradiation therapy does not increase risk of anastomotic leak in patients with gastric cancer. Int J Radiat Oncol Biol Phys. 2017;99(3):660–6.
Ikoma N, Chen HC, Wang X, et al. Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol. 2017;24(9):2679–87.
John P. Klein MLM. Survival Analysis: Techniques for Censored and Truncated Data (Statistics for Biology and Health). Berlin: Springer; 2005.
David W. Hosmer Jr., Lemeshow S. Applied Logistic Regression, 3rd edn. New York: Wiley; 2013
Therneau, TM and Grambsch P. Modeling Survival Data. New York: Springer; 2000.
Zanoni A, Verlato G, Giacopuzzi S, et al. ypN0: Does it matter how you get there? Nodal downstaging in esophageal cancer. Ann Surg Oncol. 2016;23(5):998–1004.
Sano T, Kobori O, Nagawa H, Muto T. The macroscopic diagnosis of lymph node metastasis from early gastric cancer. Surg Today. 1994;24(1):37–9.
Seto Y, Nagawa H, Muto T. Intra-operative diagnosis of N2 lymph node metastasis of gastric cancer. Hepatogastroenterology. 1997;44(15):838–41.
Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12(1):6–22.
Ikoma N, Lee JH, Bhutani MS, et al. Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonography. J Gastrointest Oncol. 2017;8(6),1009.
Disclosures
The authors have no conflicts of interest to disclose. Supported by the NIH/NCI under award number P30CA016672 and used the Clinical Trials Support Resource.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ikoma, N., Estrella, J.S., Hofstetter, W. et al. Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved. Ann Surg Oncol 25, 2012–2017 (2018). https://doi.org/10.1245/s10434-018-6471-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6471-0